Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin | Zendy

Nghia Nguyen | Zendy; Shelley A. McCormack | Zendy; Philip Vutien | Zendy; Brittany E. Yee | Zendy; Pardha Devaki | Zendy; D Jencks | Zendy; Mindie H. Nguyen | Zendy

Open Access

Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin

Author(s) -

Nghia Nguyen,

Shelley A. McCormack,

Philip Vutien,

Brittany E. Yee,

Pardha Devaki,

D Jencks,

Mindie H. Nguyen

Publication year - 2015

Publication title -

intervirology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.641

H-Index - 61

eISSN - 1423-0100

pISSN - 0300-5526

DOI - 10.1159/000369097

Subject(s) - ribavirin , medicine , pegylated interferon , hepatitis c virus , gastroenterology , genotype , hepatitis c , virology , hepatitis b , virus , biology , gene , biochemistry

Our goal was to systematically and quantitatively assess treatment response between Asian patients with hepatitis C virus genotype 6 (HCV-6) and hepatitis C virus genotype 1 (HCV-1) treated for 48 weeks with pegylated interferon and ribavirin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research